These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
209 related items for PubMed ID: 17489667
1. Nebivolol for heart failure in the elderly. Tavazzi L. Expert Rev Cardiovasc Ther; 2007 May; 5(3):423-33. PubMed ID: 17489667 [Abstract] [Full Text] [Related]
2. Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure). van Veldhuisen DJ, Cohen-Solal A, Böhm M, Anker SD, Babalis D, Roughton M, Coats AJ, Poole-Wilson PA, Flather MD, SENIORS Investigators. J Am Coll Cardiol; 2009 Jun 09; 53(23):2150-8. PubMed ID: 19497441 [Abstract] [Full Text] [Related]
3. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Flather MD, Shibata MC, Coats AJ, Van Veldhuisen DJ, Parkhomenko A, Borbola J, Cohen-Solal A, Dumitrascu D, Ferrari R, Lechat P, Soler-Soler J, Tavazzi L, Spinarova L, Toman J, Böhm M, Anker SD, Thompson SG, Poole-Wilson PA, SENIORS Investigators. Eur Heart J; 2005 Feb 09; 26(3):215-25. PubMed ID: 15642700 [Abstract] [Full Text] [Related]
4. [Influence of the beta-blocker nebivolol on left ventricular function in patients with chronic heart failure]. Wolf SC, Buck-Müller N, Görner S, Risler T, Brehm BR. Med Klin (Munich); 2003 Jan 15; 98(1):1-6. PubMed ID: 12540987 [Abstract] [Full Text] [Related]
5. Influence of diabetes mellitus and hyperglycemia on prognosis in patients > or =70 years old with heart failure and effects of nebivolol (data from the Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors with heart failure [SENIORS]). de Boer RA, Doehner W, van der Horst IC, Anker SD, Babalis D, Roughton M, Coats AJ, Flather MD, van Veldhuisen DJ, SENIORS Investigators. Am J Cardiol; 2010 Jul 01; 106(1):78-86.e1. PubMed ID: 20609652 [Abstract] [Full Text] [Related]
6. The role of the new beta-blockers in treating cardiovascular disease. Weber MA. Am J Hypertens; 2005 Dec 01; 18(12 Pt 2):169S-176S. PubMed ID: 16373195 [Abstract] [Full Text] [Related]
7. Nebivolol: a third-generation beta-blocker for hypertension. Cheng JW. Clin Ther; 2009 Mar 01; 31(3):447-62. PubMed ID: 19393838 [Abstract] [Full Text] [Related]
8. Nebivolol: a third-generation beta-adrenergic blocker. Veverka A, Nuzum DS, Jolly JL. Ann Pharmacother; 2006 Mar 01; 40(7-8):1353-60. PubMed ID: 16822893 [Abstract] [Full Text] [Related]
9. Tolerability and dose-related effects of nebivolol in elderly patients with heart failure: data from the Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS) trial. Dobre D, van Veldhuisen DJ, Mordenti G, Vintila M, Haaijer-Ruskamp FM, Coats AJ, Poole-Wilson PA, Flather MD, SENIORS Investigators. Am Heart J; 2007 Jul 01; 154(1):109-15. PubMed ID: 17584562 [Abstract] [Full Text] [Related]
10. Effects of nebivolol on left ventricular function in elderly patients with chronic heart failure: results of the ENECA study. Edes I, Gasior Z, Wita K. Eur J Heart Fail; 2005 Jun 01; 7(4):631-9. PubMed ID: 15921805 [Abstract] [Full Text] [Related]
11. Clinical and economic aspects of the use of nebivolol in the treatment of elderly patients with heart failure. Del Sindaco D, Tinti MD, Monzo L, Pulignano G. Clin Interv Aging; 2010 Dec 03; 5():381-93. PubMed ID: 21152240 [Abstract] [Full Text] [Related]
12. Nebivolol: new therapy update. Sule SS, Frishman W. Cardiol Rev; 2006 Dec 03; 14(5):259-64. PubMed ID: 16924166 [Abstract] [Full Text] [Related]
13. Nebivolol in hypertension: a double-blind placebo-controlled multicenter study assessing its antihypertensive efficacy and impact on quality of life. Van Bortel LM, Breed JG, Joosten J, Kragten JA, Lustermans FA, Mooij JM. J Cardiovasc Pharmacol; 1993 Jun 03; 21(6):856-62. PubMed ID: 7687708 [Abstract] [Full Text] [Related]
14. [Non invasive evaluation of cardiovascular effects of nebivolol in patients with cardiac insufficiency]. Boutelant S, Lechat P, Komajda M, Isnard R, Salloum J, Gagey S, Bertholon JF, Grosgogeat Y. Arch Mal Coeur Vaiss; 1992 Jun 03; 85(6):863-70. PubMed ID: 1358044 [Abstract] [Full Text] [Related]
15. [Role of the L-arginine/nitric oxide system in the action of nebivolol]. Brodde OE, Philipp T. Dtsch Med Wochenschr; 2006 Nov 10; 131(45):2545-50. PubMed ID: 17091442 [Abstract] [Full Text] [Related]
16. Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study. Conraads VM, Metra M, Kamp O, De Keulenaer GW, Pieske B, Zamorano J, Vardas PE, Böhm M, Dei Cas L. Eur J Heart Fail; 2012 Feb 10; 14(2):219-25. PubMed ID: 22147202 [Abstract] [Full Text] [Related]
17. Nebivolol for the treatment of heart failure. Riva N, Lip GY. Expert Opin Investig Drugs; 2011 Dec 10; 20(12):1733-46. PubMed ID: 21980961 [Abstract] [Full Text] [Related]
18. Beta-blockers in the management of hypertension: focus on nebivolol. Wojciechowski D, Papademetriou V. Expert Rev Cardiovasc Ther; 2008 Apr 10; 6(4):471-9. PubMed ID: 18402537 [Abstract] [Full Text] [Related]
19. Beta-adrenoceptor antagonists in elderly patients with chronic heart failure: therapeutic potential of third-generation agents. Coats AJ. Drugs Aging; 2006 Apr 10; 23(2):93-9. PubMed ID: 16536633 [Abstract] [Full Text] [Related]
20. β-blockade with nebivolol for prevention of acute ischaemic events in elderly patients with heart failure. Ambrosio G, Flather MD, Böhm M, Cohen-Solal A, Murrone A, Mascagni F, Spinucci G, Conti MG, van Veldhuisen DJ, Tavazzi L, Coats AJ. Heart; 2011 Feb 10; 97(3):209-14. PubMed ID: 21138861 [Abstract] [Full Text] [Related] Page: [Next] [New Search]